| Systematic (IUPAC) name | |
|---|---|
| (RS)-1-(4-methoxyphenyl)-2-(1-pyrrolidinyl)-1-propanone | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 6430836 |
| Chemical data | |
| Formula | C14H19NO2 |
| Mol. mass | 233.305 g/mol |
| SMILES | eMolecules & PubChem |
4'-Methoxy-α-pyrrolidinopropiophenone (MOPPP) is a stimulant drug. It is structurally related to α-PPP in the same way that PMA is related to amphetamine: a methoxy group has been added to the 4-position on the phenyl ring. MOPPP was sold in Germany as a designer drug in the late 1990s and early 2000s,[1][2][3] along with a number of other pyrrolidinophenone derivatives,[4][5] although it has never achieved the same international popularity as its better-known relations α-PPP and MDPV.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)